TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

Beyond Meat Lead
Play
INVESTING

Top Shorted Stocks by Short Interest: Beyond Meat, SunPower

Gogo Inflight Internet Lead
INVESTING

Most Heavily Shorted Stocks by Float Shorted: PubMatic, Gogo

PRESS RELEASES

Esperion To Report Fourth Quarter And Full Year 2020 Financial Results February 23, 2021

PRESS RELEASES

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PRESS RELEASES

ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results And Further Commits To Unmet Patient Needs With Oral PCSK9 Inhibitor Program

PRESS RELEASES

First-in-class Cholesterol-lowering Treatment NILEMDO® * (bempedoic Acid) Tablet And Its Combination With Ezetimibe NUSTENDI® * (bempedoic Acid And Ezetimibe) Tablet Approved In Switzerland

PRESS RELEASES

Esperion Launches U.S. Direct-to-Consumer Campaign To Accelerate Awareness Of NEXLETOL® (bempedoic Acid) Tablets And Increase Awareness Of Bad Cholesterol

China's Technology Start-ups Make A Spectacular Comeback From The Dog House Of The 2015 Stock Market Rout
JIM CRAMER

Coronavirus and Your Portfolio: Cramer's 'Mad Money' Recap (Tuesday 2/25/20)

Dow Futures Push Further Into Record Highs as Trump Signals China Trade Progress
JIM CRAMER

Tsunami of Innovation: Cramer's 'Mad Money' Recap

AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round
JIM CRAMER

AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round

3 Cutting-Edge Biotech Stocks That Can Double in Value
STOCKS

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

Delta Soars on Better-Than-Expected Profit, Revenue Offsetting Fuel Costs
JIM CRAMER

Delta Air Lines, BioTelemetry, TransUnion: 'Mad Money' Lightning Round

Best and Worst Closed-End Funds
JIM CRAMER

Are Stocks Cheaper Than We Think?: Cramer's 'Mad Money' Recap

Apple Gains Put Dow on Track for Sixth Straight Record Close
JIM CRAMER

Markets Focus on Business: Cramer's 'Mad Money' Recap

3 Health Care Stocks to Own for 2017
HEALTH

Celgene, Vertex and Spark Among Jefferies' Top Biotech Picks

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Akebia Shares Down After Pricing Stock Offering

Apple iPhone Shipment Estimates Slashed by 11 Million, Bank Sees 3-4 Week Delay in New Smartphone
STOCKS

Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct

Alibaba Open at Record High as Investors Go Berserk After Sales Forecasts Crush Estimates
JIM CRAMER

Alibaba, Coherent, Advanced Micro Devices: 'Mad Money' Lightning Round

One of Caterpillar's Most Important Measures Is Rising, Which Could Help Send the Stock Up 15%
JIM CRAMER

These Sleeper Stocks Are Soaring: Cramer's 'Mad Money' Recap

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Premarket Movers: Esperion, Minerva and BioCryst

AMD Shares Plunge on Q3 Earnings and Revenue Miss
STOCKS

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Premarket Movers: CytomX, Aevi, Esperion

AveXis, Esperion and Amgen Among Biotech Movers
HEALTH

AveXis, Esperion and Amgen Among Biotech Movers

What Tax Reform Means for PayPal's Bottom Line
JIM CRAMER

PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round

Why Billionaire Warren Buffett Has Dumped IBM Shares And Loaded Up on Apple
JIM CRAMER

Here's Why Buffett Is So Bullish About This Market: Cramer's 'Mad Money' Recap